Gritstone bio, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2017 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Gritstone bio, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2017 to Q4 2023.
  • Gritstone bio, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $189M, a 17.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $189M +$27.8M +17.3% Dec 31, 2023 10-K 2024-03-05
Q4 2022 $161M +$33.9M +26.7% Dec 31, 2022 10-K 2024-03-05
Q4 2021 $127M +$25.2M +24.8% Dec 31, 2021 10-K 2023-03-09
Q4 2020 $102M +$42.4M +71.5% Dec 31, 2020 10-K 2022-03-10
Q4 2019 $59.3M +$24.9M +72.1% Dec 31, 2019 10-K 2021-03-11
Q4 2018 $34.5M +$18.4M +115% Dec 31, 2018 10-K 2020-03-11
Q4 2017 $16.1M Dec 31, 2017 10-K 2019-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.